Principal Financial Group’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-97,926
Closed -$1.81M 2184
2024
Q4
$1.81M Buy
97,926
+3,615
+4% +$70.6K ﹤0.01% 1808
2024
Q3
$2.05M Sell
94,311
-6,020
-6% -$135K ﹤0.01% 1762
2024
Q2
$1.97M Sell
100,331
-4,347
-4% -$90.8K ﹤0.01% 1769
2024
Q1
$2.27M Sell
104,678
-9,164
-8% -$228K ﹤0.01% 1759
2023
Q4
$3.29M Sell
113,842
-2,431
-2% -$65K ﹤0.01% 1677
2023
Q3
$3.11M Sell
116,273
-1,088
-0.9% -$37.1K ﹤0.01% 1670
2023
Q2
$4.35M Sell
117,361
-8,340
-7% -$291K ﹤0.01% 1589
2023
Q1
$3.92M Sell
125,701
-2,762
-2% -$88.9K ﹤0.01% 1619
2022
Q4
$3.83M Buy
128,463
+3,483
+3% +$125K ﹤0.01% 1613
2022
Q3
$4.76M Buy
124,980
+3,225
+3% +$162K ﹤0.01% 1509
2022
Q2
$6.64M Sell
121,755
-6,245
-5% -$343K ﹤0.01% 1452
2022
Q1
$7.99M Sell
128,000
-3,175
-2% -$209K 0.01% 1492
2021
Q4
$13.2M Buy
131,175
+165
+0.1% +$14.5K 0.01% 1240
2021
Q3
$11.8M Buy
131,010
+6,000
+5% +$545K 0.01% 1314
2021
Q2
$11.5M Sell
125,010
-3,806
-3% -$304K 0.01% 1354
2021
Q1
$12.4M Buy
128,816
+34,118
+36% +$3.52M 0.01% 1275
2020
Q4
$4.93M Sell
94,698
-9,420
-9% -$394K ﹤0.01% 1566
2020
Q3
$4.17M Buy
104,118
+93,672
+897% +$2.93M ﹤0.01% 1526
2020
Q2
$167K Buy
+10,446
New +$160K ﹤0.01% 2211

Other funds holding FLGT

Principal Financial Group's FLGT Position: Q1 2025 in Review

Principal Financial Group sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 97,926 shares — an estimated $1.81M sold.

Principal Financial Group first reported a position in FLGT in Q2 2020 and held it in 19 quarters. The position peaked at $13.2M in Q4 2021. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

  • Principal Financial Group reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
  • Principal Financial Group sold 97,926 Fulgent Genetics shares in Q1 2025, an estimated $1.81M.
  • Principal Financial Group first reported a position in Fulgent Genetics in Q2 2020 and held it in 19 quarters.
  • Principal Financial Group's Fulgent Genetics position peaked at $13.2M in Q4 2021.
  • 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Principal Financial Group's 13F filing for Q1 2025, filed 28 Apr 2025.